Erythema multiforme after meningitis vaccine: patient safety concerns with repeat immunization.
Publication/Presentation Date
11-1-2006
Abstract
A 20-year-old college student developed an immunologic hypersensitivity reaction, erythema multiforme minor, 1-2 weeks after receiving a meningococcal conjugate vaccine. He had no history of erythema multiforme, nor had he received any other vaccine or drug therapy. The temporal relationship between the development of erythema multiforme and the vaccination suggests that the meningitis vaccine probably was the causal agent. The occurrence of this distinct cutaneous reaction, with the potential for a serious complication such as erythema multiforme major or Stevens-Johnson syndrome on rechallenge, should serve as a warning against repeated booster vaccinations in patients who develop reactions such as this one.
Volume
26
Issue
11
First Page
1658
Last Page
1661
ISSN
0277-0008
Published In/Presented At
Studdiford, J., Oppenheim, L., McCann, E., & Altshuler, M. (2006). Erythema multiforme after meningitis vaccine: patient safety concerns with repeat immunization. Pharmacotherapy, 26(11), 1658–1661. https://doi.org/10.1592/phco.26.11.1658
Disciplines
Business Administration, Management, and Operations | Health and Medical Administration | Management Sciences and Quantitative Methods
PubMedID
17064213
Department(s)
Administration and Leadership
Document Type
Article